Categories Uncategorized

Earth Science Tech, Inc. (ETST) Sets Testing Dates for Cannabinoid-Based Products

  • Quebec grant will help develop its cannabinoid products; ETST testing will commence in 4Q2018 on formula patents aimed at preventing cancer and other diseases
  • ETST will apply for trademark, finalize packaging for debut of medical device designed to diminish sexually transmitted infections; women will be target audience for this product
  • Company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol

Earth Science Tech, Inc. (OTC: ETST) has established testing dates for three of its cannabinoid-based (CBD) products. Funded by a grant from Quebec, ETST is now prototyping three CBD patent formulas. A superfood edible is expected to be ready for 4Q2018. The company is scheduled to begin in vitro testing on its first batch of formulas in the summer of 2019, with a goal of demonstrating the superior antioxidant properties and anti-proliferative effects on breast cancer cells, it announced (http://cnw.fm/Qs2C4).

The goal of these products is to stop inflammation, maintain quality of life, and help prevent cancer and other degenerative diseases. The branding of these three products is in the planning stage.

ETST, a biotech company based in Doral, Florida, has repositioned its line of full-spectrum CBD offerings. It also conducts R&D for low cost, non-invasive medical devices as it concentrates on manufacturing, marketing and distributing its cannabinoid products to the nutraceutical and pharmaceutical markets.

Its MSN-2 medical device is in its final stage prior to the launch of large-scale marketing. ETST is working with Montreal-based Acceleration, Design et Innovation Inc. to aid in the preparation and introduction. Final packaging is being designed to appeal to its target global audience of women. The device is developed to prevent chlamydia and other sexually transmitted infections.

“The official launch of this medical device is a little like giving birth,” Dr. Michel Aube, CEO and chief science officer of ETST, stated in a news release. “It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name.”

ETST holds several wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit, accepting grants and donations to conduct additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines. It also has subsidiary Canno Inno Laboratories Inc., a strategic Montreal, Canada-based company formed to provide ETST with access to government grants.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

Restrictions, State Bans Threaten the Thriving Market for Hemp-Sourced Intoxicants

Legislators in states across the country are working towards strictly regulating and/or banning intoxicating hemp…

1 month ago

Senate Panel in Florida Starts Discussing Bill Restricting Hemp Products

A proposal introduced by Sen. Colleen Burton that would ban delta-8 THC hemp products is…

1 month ago

California Extends Prohibition of Hemp Products with THC

California recently extended a ban on intoxicating hemp products with THC that was set to…

1 month ago

Poll Finds More Consumers Want to Use Hemp Delivery Services

A new poll has determined that frequent consumers of marijuana like using delivery platforms to…

1 month ago

Hemp Seeds Are Attracting Attention as an Alternative Source of Protein

The demand for plant-based proteins has increased in the last couple of years as consumer…

2 months ago

UK Approves 5 CBD Applications, Doubles Down on 10mg Cap

The CBD market in the United Kingdom has grown since the compound’s extracts were designated…

2 months ago